eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystoid macular dystrophy |
| Comorbidity | C0011847|diabetes |
| Sentences | 13 |
| PubMedID- 20507015 | Atorvastatin for diabetic macular edema in patients with diabetes mellitus and elevated serum cholesterol. |
| PubMedID- 24741610 | According to another study, the prevalence of macular edema in patients with recently diagnosed diabetes is 0 to 3%, increasing to 29% in diabetic patients with over 20 years of disease [9]. |
| PubMedID- 24330936 | There is an urgent requirement to find effective therapeutic procedures for the treatment of refractory eye diseases of posterior segment such as posterior uveitis, proliferative vitreoretinopathy, and macular edema associated with diabetes and retinal vein occlusion. |
| PubMedID- 25811020 | Therefore, the analysis of the aqueous humor provides useful tool in understanding the pathophysiology and treatment responses of macular edema in patients with diabetes following uncomplicated phacoemulsification cataract surgery. |
| PubMedID- 22548042 | Regarding drug-induced macular edema in patients with diabetes, thiazolidinediones, a class of drug that binds the peroxisome proliferator-activated receptor-γ to reduce insulin resistance in type 2 diabetes, have been reported to be associated with macular edema [9]. |
| PubMedID- 21742309 | Focal/grid laser still has a role for patients with macular edema resulting from diabetes or venous occlusion that is poorly responsive to anti-vegf agents and in patients who are unable or unwilling to return for frequent injections. |
| PubMedID- 23528703 | Methods: in this prospective cohort study, 13 consecutive patients with vision loss because of clinically significant macular edema associated with diabetes mellitus type 2 underwent grid laser treatment (pascal). |
| PubMedID- 25196766 | The vitreous has been implicated as a cause of macular edema in people with diabetes via several mechanical and physiologic mechanisms, all of which are postulated to lead to increased vascular permeability. |
| PubMedID- 24753783 | A 57-year-old white male had type 2 diabetes complicated by macular edema, cataracts, distal symmetrical polyneuropathy, autonomic neuropathy, hypertension, and ischemic heart disease for at least 17 years. |
| PubMedID- 22183994 | Purpose: treatment of diffuse macular edema in diabetes mellitus is currently unsatisfactory. |
| PubMedID- 22082694 | Methods: sixty patients receiving intravitreal injections over 15 months for macular edema because of diabetes, age-related macular degeneration, or retinal vein occlusion who were randomized into 3 groups to receive 1 of 3 commonly used forms of anesthesia-tetravisc, proparacaine hcl, or tetracaine hcl-before receiving intravitreal injection were studied. |
| PubMedID- 20635822 | Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from medline and embase. |
| PubMedID- 21860693 | Managing diabetic macular edema: the leading cause of diabetes blindness. |
Page: 1